首页> 外文期刊>Science >C57BL/6N Mutation in Cytoplasmic FMRP interacting protein 2 Regulates Cocaine Response
【24h】

C57BL/6N Mutation in Cytoplasmic FMRP interacting protein 2 Regulates Cocaine Response

机译:细胞质FMRP相互作用蛋白2中的C57BL / 6N突变调节可卡因反应。

获取原文
获取原文并翻译 | 示例
       

摘要

The inbred mouse C57BL/6J is the reference strain for genome sequence and for most behavioral and physiological phenotypes. However, the International Knockout Mouse Consortium uses an embryonic stem cell line derived from a related C57BL/6N substrain. We found that C57BL/6N has a lower acute and sensitized response to cocaine and methamphetamine. We mapped a single causative locus and identified a nonsynonymous mutation of serine to phenylalanine (S968F) in Cytoplasmic FMRP interacting protein 2 (Cyfip2) as the causative variant. The S968F mutation destabilizes CYFIP2, and deletion of the C57BL/6N mutant allele leads to acute and sensitized cocaine-response phenotypes. We propose that CYFIP2 is a key regulator of cocaine response in mammals and present a framework to use mouse substrains to identify previously unknown genes and alleles regulating behavior.
机译:自交小鼠C57BL / 6J是基因组序列以及大多数行为和生理表型的参考菌株。但是,国际基因敲除小鼠协会使用的是来自相关C57BL / 6N亚菌株的胚胎干细胞系。我们发现C57BL / 6N对可卡因和甲基苯丙胺的急性和致敏反应较低。我们绘制了一个单一的致病基因座,并确定了胞质FMRP相互作用蛋白2(Cyfip2)中丝氨酸对苯丙氨酸的非同义突变(S968F)。 S968F突变破坏CYFIP2的稳定性,而C57BL / 6N突变等位基因的缺失会导致急性和致敏的可卡因反应表型。我们建议CYFIP2是可卡因反应在哺乳动物中的关键调节器,并提出了使用小鼠亚菌株来鉴定以前未知的基因和等位基因调节行为的框架。

著录项

  • 来源
    《Science》 |2013年第6165期|1508-1512|共5页
  • 作者单位

    Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX 75390-9111, USA,Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390-9111, USA;

    Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX 75390-9111, USA;

    Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX 75390-9111, USA;

    lntramural Research Program, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Baltimore, MD 21224, USA,Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390-9127, USA;

    Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX 75390-9111, USA,Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390-9127, USA;

    Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX 75390-9111, USA;

    Department of Neurobiology, Northwestern University, Evanston, IL 60208, USA;

    Department of Genetics, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, USA;

    Jackson Laboratory, Bar Harbor, ME 04609, USA;

    lntramural Research Program, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Baltimore, MD 21224, USA,Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston, Houston, TX 77030, USA;

    Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX 75390-9111, USA,Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390-9111, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:53:07

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号